X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (39576) 39576
Newsletter (140) 140
Newspaper Article (136) 136
Book Chapter (83) 83
Magazine Article (75) 75
Book / eBook (49) 49
Publication (9) 9
Dissertation (8) 8
Web Resource (6) 6
Book Review (5) 5
Conference Proceeding (4) 4
Government Document (4) 4
Reference (2) 2
Report (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (35776) 35776
female (34077) 34077
middle aged (16653) 16653
oncology (15857) 15857
adult (15567) 15567
ovarian cancer (14413) 14413
ovarian neoplasms - pathology (13079) 13079
aged (11981) 11981
ovarian neoplasms - surgery (11212) 11212
cancer (10696) 10696
obstetrics & gynecology (8743) 8743
prognosis (6798) 6798
chemotherapy (6712) 6712
surgery (6297) 6297
ovarian neoplasms - drug therapy (6179) 6179
neoplasm staging (5713) 5713
carcinoma (5581) 5581
tumors (5190) 5190
ovarian neoplasms - diagnosis (4592) 4592
ovarian-cancer (4552) 4552
retrospective studies (4467) 4467
aged, 80 and over (4200) 4200
survival (4174) 4174
ovarian neoplasms - genetics (4072) 4072
research (4032) 4032
male (3931) 3931
treatment outcome (3738) 3738
care and treatment (3646) 3646
adolescent (3554) 3554
ovarian neoplasms - mortality (3407) 3407
health aspects (3377) 3377
metastasis (3369) 3369
breast cancer (3329) 3329
women (3325) 3325
diagnosis (3185) 3185
analysis (3183) 3183
expression (3136) 3136
antineoplastic combined chemotherapy protocols - therapeutic use (3085) 3085
ovarian neoplasms - therapy (2999) 2999
risk factors (2988) 2988
animals (2886) 2886
pathology (2771) 2771
cell line, tumor (2731) 2731
obstetrics and gynecology (2725) 2725
ovarian neoplasms - metabolism (2722) 2722
immunohistochemistry (2718) 2718
medicine & public health (2684) 2684
breast-cancer (2479) 2479
hematology, oncology and palliative medicine (2478) 2478
combined modality therapy (2464) 2464
genetic aspects (2411) 2411
follow-up studies (2388) 2388
young adult (2371) 2371
mutation (2303) 2303
survival rate (2287) 2287
survival analysis (2065) 2065
diagnosis, differential (2042) 2042
cisplatin (2015) 2015
ovariectomy (1978) 1978
disease-free survival (1974) 1974
pregnancy (1968) 1968
gene expression (1932) 1932
risk (1897) 1897
cancer therapies (1881) 1881
medical prognosis (1881) 1881
ovarian neoplasms - complications (1875) 1875
breast neoplasms - genetics (1868) 1868
ovarian carcinoma (1839) 1839
apoptosis (1810) 1810
management (1784) 1784
proteins (1783) 1783
ovarian neoplasms (1782) 1782
antineoplastic agents - therapeutic use (1746) 1746
patients (1740) 1740
carcinoma, ovarian epithelial (1728) 1728
mice (1725) 1725
hysterectomy (1693) 1693
medicine (1680) 1680
development and progression (1677) 1677
ovary (1675) 1675
ovarian neoplasms - diagnostic imaging (1616) 1616
oncology, experimental (1604) 1604
child (1581) 1581
paclitaxel (1572) 1572
laparoscopy (1527) 1527
ovarian neoplasms - blood (1526) 1526
research article (1526) 1526
gynecology (1502) 1502
chemotherapy, adjuvant (1496) 1496
prospective studies (1457) 1457
gene expression regulation, neoplastic (1450) 1450
time factors (1436) 1436
therapy (1374) 1374
studies (1321) 1321
cancer research (1285) 1285
neoplasms, glandular and epithelial - pathology (1266) 1266
cisplatin - administration & dosage (1259) 1259
biomarkers (1257) 1257
medical research (1250) 1250
ultrasonography (1226) 1226
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (15) 15
Online Resources - Online (8) 8
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (6) 6
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Lakeridge Health Sciences - Online (1) 1
Scarborough Hospital - General (1) 1
St. Michael's Hospital - Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (36986) 36986
German (851) 851
French (743) 743
Japanese (505) 505
Chinese (310) 310
Polish (285) 285
Russian (259) 259
Italian (251) 251
Spanish (210) 210
Bulgarian (84) 84
Korean (84) 84
Czech (73) 73
Dutch (60) 60
Hungarian (49) 49
Portuguese (49) 49
Danish (46) 46
Croatian (27) 27
Romanian (26) 26
Hebrew (24) 24
Serbian (23) 23
Norwegian (20) 20
Ukrainian (19) 19
Swedish (17) 17
Turkish (14) 14
Finnish (7) 7
Slovak (7) 7
Arabic (6) 6
Greek (2) 2
Lithuanian (2) 2
Persian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 78, Issue 1, pp. 127 - 135
Purpose To examine the risk of subsequent primary malignancies (SPMs) in women diagnosed with endometrial cancer. Methods and Materials The National Cancer... 
Radiology | Hematology, Oncology and Palliative Medicine | Radiation-induced malignancies | HNPCC | Endometrial cancer | Second primary malignancies | SURGERY | LYNCH-SYNDROME | NONPOLYPOSIS COLORECTAL-CANCER | 2ND PRIMARY CANCERS | RISK | CERVICAL-CANCER | RADIATION-THERAPY | UTERINE | ONCOLOGY | OVARIAN | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | United States - epidemiology | Colonic Neoplasms - genetics | Follow-Up Studies | Humans | Middle Aged | Bone Neoplasms - epidemiology | Pharyngeal Neoplasms - etiology | Esophageal Neoplasms - epidemiology | Incidence | Vaginal Neoplasms - genetics | Young Adult | Neoplasms, Radiation-Induced - genetics | Endometrial Neoplasms - genetics | Lung Neoplasms - etiology | Aged, 80 and over | Intestine, Small - radiation effects | Bone Neoplasms - genetics | Neoplasms, Second Primary - genetics | Mouth Neoplasms - genetics | SEER Program | Risk Assessment | Vaginal Neoplasms - etiology | Mouth Neoplasms - etiology | Neoplasms, Second Primary - epidemiology | Mouth Neoplasms - epidemiology | Pharyngeal Neoplasms - genetics | Vaginal Neoplasms - epidemiology | Adolescent | Pharyngeal Neoplasms - epidemiology | Endometrial Neoplasms - radiotherapy | Esophageal Neoplasms - etiology | Age Factors | Neoplasms, Radiation-Induced - etiology | Urinary Bladder Neoplasms - genetics | Adult | Female | Intestinal Neoplasms - genetics | Urinary Bladder Neoplasms - epidemiology | Colonic Neoplasms - etiology | Lung Neoplasms - genetics | Urinary Bladder Neoplasms - etiology | Colonic Neoplasms - epidemiology | Intestinal Neoplasms - etiology | Intestinal Neoplasms - epidemiology | Bone Neoplasms - etiology | Neoplasms, Second Primary - etiology | Lung Neoplasms - epidemiology | Esophageal Neoplasms - genetics | Aged | Neoplasms, Radiation-Induced - epidemiology | Genetic aspects | Research | Oncology, Experimental | Cancer | Index Medicus | LARGE INTESTINE | GASTROINTESTINAL TRACT | ORAL CAVITY | ESOPHAGUS | DIGESTIVE SYSTEM | LUNGS | MEDICINE | PHARYNX | THERAPY | RADIOLOGY AND NUCLEAR MEDICINE | BLADDER | RADIOTHERAPY | RADIOLOGY | SMALL INTESTINE | NEOPLASMS | UTERUS | INTESTINES | NUCLEAR MEDICINE | FEMALE GENITALS | ORGANS | URINARY TRACT | DISEASES | RESPIRATORY SYSTEM | BRACHYTHERAPY | BODY
Journal Article
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 2013, Volume 209, Issue 5, pp. 462.e1 - 462.e11
Journal Article
Gynecologic oncology, ISSN 0090-8258, 2013, Volume 131, Issue 1, pp. 36 - 41
Abstract Objective We evaluated the clinical outcome and prognostic factors for post-relapse survival (PRS) in a large retrospective series of ovarian cancer... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Anatomic site of disease | Favourable prognosis | Recurrent ovarian cancer | Localized relapse | Secondary debulking surgery | SURVIVAL | METASTASIS | SECONDARY CYTOREDUCTIVE SURGERY | IDENTIFICATION | CHEMOTHERAPY | OBSTETRICS & GYNECOLOGY | 2ND-LINE | THERAPY | CISPLATIN | ONCOLOGY | RECURRENT | CARCINOMA | Lymph Nodes - pathology | Follow-Up Studies | Lymph Nodes - surgery | Humans | Middle Aged | Brain Neoplasms - pathology | Ovarian Neoplasms - pathology | Lung Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Brain Neoplasms - surgery | Neoplasm Recurrence, Local - pathology | Platinum Compounds - therapeutic use | Young Adult | Brain Neoplasms - secondary | Lung Neoplasms - secondary | Aged, 80 and over | Adult | Female | Liver Neoplasms - pathology | Retrospective Studies | Liver Neoplasms - secondary | Carcinoma - secondary | Peritoneal Neoplasms - secondary | Carcinoma - drug therapy | Peritoneal Neoplasms - pathology | Neoplasms, Glandular and Epithelial - pathology | Neoplasm Recurrence, Local - therapy | Peritoneal Neoplasms - surgery | Neoplasms, Glandular and Epithelial - therapy | Liver Neoplasms - surgery | Lymphatic Metastasis | Splenic Neoplasms - surgery | Splenic Neoplasms - pathology | Carcinoma, Ovarian Epithelial | Ovarian Neoplasms - therapy | Carcinoma - therapy | Aged | Neoplasm Staging | Splenic Neoplasms - secondary | Care and treatment | Cancer patients | Prognosis | Patient outcomes | Ovarian cancer
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2006, Volume 354, Issue 3, pp. 261 - 269
Journal Article
Gynecologic oncology, ISSN 0090-8258, 2013, Volume 131, Issue 2, pp. 341 - 346
Journal Article
Journal Article
Gynecologic oncology, ISSN 0090-8258, 2012, Volume 124, Issue 1, pp. 10 - 14
Journal Article
PloS one, ISSN 1932-6203, 12/2015, Volume 10, Issue 12, p. e0145754
Background High-grade serous ovarian and endometrial cancers are the most lethal female reproductive tract malignancies worldwide. In part, failure to treat... 
CA-125 | MULTIDISCIPLINARY SCIENCES | EPITHELIAL OVARIAN-CANCER | Endometrial Neoplasms - mortality | Humans | Middle Aged | Ovarian Neoplasms - mortality | Genital Neoplasms, Female - drug therapy | DNA, Neoplasm - blood | Endometrial Neoplasms - genetics | Adult | Female | Neoplasm Recurrence, Local - blood | Ovarian Neoplasms - drug therapy | Genital Neoplasms, Female - genetics | CA-125 Antigen - blood | Ovarian Neoplasms - blood | Genital Neoplasms, Female - blood | Mutation - genetics | Breast Neoplasms - drug therapy | Biomarkers, Tumor - blood | Genital Neoplasms, Female - mortality | Exome - genetics | Breast Neoplasms - genetics | Breast Neoplasms - blood | Breast Neoplasms - mortality | Endometrial Neoplasms - drug therapy | Neoplasm Recurrence, Local - genetics | Aged | Biomarkers, Tumor - genetics | DNA, Neoplasm - genetics | Endometrial Neoplasms - blood | Physiological aspects | Prognosis | Biological markers | Genital cancer | Tumors | Plasma | Scanning | Ovarian carcinoma | Fallopian tube | Cancer therapies | Ovarian cancer | Gene sequencing | Computed tomography | Surgery | Quality | Imaging | Endometrium | Deoxyribonucleic acid--DNA | DNA probes | Gynecology | Breast cancer | Patients | Survival | Obstetrics | Medicine | Lead time | Chemotherapy | Surveillance | Womens health | Biomarkers | Diagnostic systems | Mutation | Reproductive system | Uterine cancer | Peritoneum | Cancer | Deoxyribonucleic acid | DNA
Journal Article
Langenbeck's archives of surgery, ISSN 1435-2451, 2013, Volume 399, Issue 1, pp. 41 - 53
Selected patients with peritoneal surface malignancies (PSM) have been treated effectively by the combination of cytoreduction surgery (CRS... 
Peritoneal surface malignancies | Medicine & Public Health | Cardiac Surgery | HIPEC | Traumatic Surgery | Cytoreductive surgery | Peritoneal carcinomatosis | Abdominal Surgery | Vascular Surgery | Thoracic Surgery | General Surgery | SURGERY | PHASE-III | SURFACE MALIGNANCY | OVARIAN-CANCER | PERIOPERATIVE INTRAPERITONEAL | COMPLETE CYTOREDUCTIVE SURGERY | GASTRIC-CANCER | PSEUDOMYXOMA-PERITONEI | COLORECTAL-CANCER | SYSTEMIC CHEMOTHERAPY | HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY | Prognosis | Pseudomyxoma Peritonei - surgery | Mesothelioma - pathology | Humans | Ovarian Neoplasms - pathology | Carcinoma - mortality | Mesothelioma - mortality | Stomach Neoplasms - pathology | Ovarian Neoplasms - mortality | Pseudomyxoma Peritonei - drug therapy | Peritoneal Neoplasms - drug therapy | Mesothelioma - surgery | Pseudomyxoma Peritonei - mortality | Hyperthermia, Induced | Pseudomyxoma Peritonei - pathology | Female | Chemotherapy, Adjuvant | Carcinoma - pathology | Ovarian Neoplasms - drug therapy | Carcinoma - secondary | Peritoneal Neoplasms - secondary | Carcinoma - drug therapy | Peritoneal Neoplasms - pathology | Intestinal Neoplasms - surgery | Intestinal Neoplasms - mortality | Carcinoma - surgery | Peritoneal Neoplasms - surgery | Combined Modality Therapy | Stomach Neoplasms - drug therapy | Peritoneal Neoplasms - mortality | Intestinal Neoplasms - pathology | Mesothelioma - drug therapy | Disease-Free Survival | Neoplasm Staging | Stomach Neoplasms - surgery | Intestinal Neoplasms - drug therapy | Stomach Neoplasms - mortality | Chemotherapy, Cancer, Regional Perfusion | Ovarian Neoplasms - surgery | Chemotherapy | Health aspects | Surgery | Analysis | Mortality | Cancer
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 2016, Volume 64, pp. 22 - 31
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 378, Issue 3, pp. 230 - 240